glp-1 clinical trial Lilly orforglipron oral phase 3 weight loss What does the science say

Description

This exploration is about GLP-1 drugs and their effect on weight loss and managing type 2 diabetes

Eli Lilly and Company Today LLY Eli Lilly and Company $1,178.01 +8.84 (+0.76%) As of 07/17/2026 03:59 PM Eastern This is a fair market value price provided by Massive

doi:10.1111/bcp.15816 186

A 5 to 10 beat per minute increase that a 35-year-old barely notices might cause fatigue, exercise intolerance, or shortness of breath in a 65-year-old

Weeks 140.25 mg weekly Weeks 580.5 mg weekly Weeks 9121.0 mg weekly Weeks 13161.7 mg weekly Week 17+2.4 mg weekly (maintenance) Weeks 142.5 mg weekly Weeks 585 mg weekly Every 4 weeks after7.5 / 10 / 12.5 / 15 mg Your prescriber may hold you at a dose longer if you're doing well or having side effects